Benchtop Automation Market By Product Type (Automated Pipetting Systems, Automated Liquid Handling Workstations, Automated Plate Handling Systems, Automated Nucleic Acid Purification Systems, Automated Colony Counters, Automated Microplate Readers, Others), By Application (Genomics, Proteomics, Drug Discovery & Development, Clinical Diagnostics, Cell Biology, Others), By Technology (Robotic Arm Integration, Optical Imaging Systems, Microfluidics-based Automation, Magnetic Bead-based Processing, Others), By Automation Level (Semi-automated Systems, Fully Automated Systems), and By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical Laboratories, Contract Research Organizations (CROs), Food & Beverage Testing Laboratories, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape Benchtop Automation Market in the coming years?

The Benchtop Automation Market accounted for USD 2.18 Billion in 2024 and USD 2.35 Billion in 2025 is expected to reach USD 5.01 Billion by 2035, growing at a CAGR of around 7.86% between 2025 and 2035. The benchtop automation market can be described as the industry that deals with small-scale automated apparatus that lies on the bench to complete laboratory tasks. Such systems eliminate the laborious task of sample preparation and analysis, and testing and make the procedures more efficient and less prone to human error in the lab environment. They find common application in pharmaceuticals, biotechnology, clinical diagnostics, and research. The demand to have results faster and more accurately and to streamline workflows in the laboratory, drives the market. Bonus growth is also being led by expertise in the fields of robotics, AI, and miniaturization.

What do industry experts say about the Benchtop Automation market trends?

“Standalone pre-analytical automated systems or benchtop units—offering smaller footprints than total laboratory automation—are often a good choice for labs with limited floor space.”

• Christoph Möellers, Vice President & General Manager, Workflow & IT Solutions, Beckman Coulter

“With automation, the key benefit is consistency… Automation is a fantastic thing to have in place, because it helps remove the day-to-day drudgery… reposition your scientists to do actual experiments, rather than having them sit in a hood, culturing and passaging cells.”

• Dr. Sukhanya Jayachandra, PhD, Senior Research Investigator & Head, Cellular Resource Group, Bristol-Myers Squibb

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Benchtop Automation market?

How does increasing laboratory efficiency impact benchtop automation adoption?

One of the driving forces masterminding the implementation of the benchtop automation system during lab experiments is to increase the efficiency of the laboratory. With increased pressure to deliver results within a shorter time and with higher accuracy, automation of processes helps in eliminating human error, streamlining the workflow, and increasing throughput as labs meet the challenge of increasing demands.

The National Institutes of Health (NIH) agrees that automation in the laboratory leads to a 30-50% reduction in the time laboratories need to perform processes, so laboratories can spend more time analyzing and being innovative instead of performing manual tasks. Moreover, the U.S. Food and Drug Administration (FDA) points out that automation favors improved standardization and reproducibility of the experiments, which is essential in clinical and pharmaceutical scenarios.

These advantages are translated into cost and increased productivity, an aspect that motivates labs to invest in the benchtop automation techniques. Overall, the motivation to achieve a higher level of efficiency by means of automation is defining contemporary lab practices and boosting the development of the benchtop automation market.

Does automation reduce human error in repetitive experimental tasks?

Human error when in charge of doing repetitive experiments is a great contributor to the benchtop automation market, which automation highly minimizes. Research published by the U.S. National Institutes of Health (NIH) indicates that, due to reduced variability caused by human factors (e.g., fatigue, distraction, or non-uniform technique), nothing less than fully automated systems results in more reliable and reproducible results.

NIH studies have found that automation of laboratory workflows can minimize sample contamination and processing error against automation by up to 30-50%. Besides, according to the report provided by the U.S. Food and Drug Administration (FDA), automation produces a high rate of test throughput that is highly accurate but eliminates the human intervention that leads to errors.

Further, the Centers for Disease Control and Prevention (CDC) mentions that automation in diagnostic laboratories enhances consistency, which is essential to patient protection and research legitimacy. This evidence highlights how benchtop automation increases the speed, minimizes human error, and guarantees a greater quality output in both experimentation and clinical laboratories.

Could complexity of integration slow down benchtop automation implementation?

Implementation of benchtop automation systems can be slowed considerably by the intricacy of the integration process. The systems can be technically strenuous whilst interfacing with existing software, laboratory, and workflow systems, and even with the laboratory devices, it may take a long time and be strenuous to achieve a seamless integration. A report released by the National Institute of Standards and Technology (NIST) indicated that challenges of integrating the systems, such as software compatibility and hardware synchronization, also lead to delays in automation adoption within the laboratory.

A research article published by the National Institutes of Health (NIH) emphasizes that complicated system integration frequently requires expert engineering skills and stringent validation procedures that increase the project deployment schedule. This complication extends the preliminary installation and the chance of downtimes in operations, which ends up slackening the wider market integration of benchtop automation technologies. Thus, integrating issues is determinant in accelerating the process of implementation and maximizing the advantage of such automation solutions.

Will expanding applications in personalized medicine drive benchtop automation demand?

Increasing use of personalized medicine is ironically set to propel the use of benchtop automation, which will also demand it significantly. Personalized medicine is another area that greatly depends on accurate and high-throughput analysis of biological specimens to customize treatment to different genetic, proteomic, and metabolic profiles on a patient-by-patient basis. The underlying automation systems on a benchtop allow workflows involving sample processing and information generation that are much faster, precise, and reproducible, which is critical in such complex workflows.

The U.S. National Institutes of Health (NIH) points out that due to the rapid development of genomic technologies, the amount of generated data has increased dramatically, thus requiring automated platforms to facilitate the processes of sample preparation and analysis. Moreover, the FDA notes that the individualized medicine solutions need to be highly quality-controlled and standardized, which is possible and supported with the help of benchtop automation.

Automation is already proven to cause a decrease in human error, and it also enhances the acceleration of diagnostic testing and drug development, and benchtop automation becomes a necessity in the development of personalized healthcare. Thus, the desire to reduce the space and versatility of the automation tools on a smaller benchtop is likely to grow exponentially as personalized medicine is becoming a reality.

Is growing interest in remote monitoring creating new automation solutions?

The increasing popularity of remote monitoring is greatly contributing to the innovation behind the benchtop automation marketplace, where the majority of the labs and research facilities are embracing the idea of customizable and automated systems that facilitate real-time data collection and remote control of benchtop equipment. This is dictated by the necessity of greater efficiency, accuracy, and safety, especially in settings where maintaining physical presence at a minimum can be essential, as has been the case during the COVID-19 pandemic.

Automation, remote monitoring, and robotic technologies have enhanced laboratory throughput up to 30%, according to the U.S. National Institutes of Health (NIH), and researchers are running experiments and controlling equipment at off-site locations. Besides, as the National Institute of Standards and Technology (NIST) points out, combining remote monitoring with automation eliminates the risk of human error and guarantees the same experimental conditions.

Such trends indicate that there has been an inclining trend toward more intelligent benchtop devices that have the capability to be connected via a wireless platform and have predictive maintenance and data analytics, which present market opportunities in the automation business. Such integration is optimal for running maintenance in labs and helps to meet regulations and data integrity, which is paramount in laboratory and clinical research spaces.

What are the key market segments in the Benchtop Automation industry?

Based on the product type, the Benchtop Automation Market is classified into Automated Pipetting Systems, Automated Liquid Handling Workstations, Automated Plate Handling Systems, Automated Nucleic Acid Purification Systems, Automated Colony Counters, Automated Microplate Readers, and Others. Automated liquid handling workstations and content and protocol management systems are the most visible segments in the benchtop automation market.

The systems play a vital role in increasing precision, reproducibility, and throughput in different laboratory procedures like sample preparation, reagent dispensing, and setting up assays. They are also flexible in several applications in genomics, drug discovery, and clinical diagnostics, which makes them in high demand. Moreover, they are imperative in present benchtop automation due to their capability in decreasing human error and saving time, thus making them inevitable in the market.

Based on the application, the Benchtop Automation Market is classified into Genomics, Proteomics, Drug Discovery & Development, Clinical Diagnostics, Cell Biology, and Others. Drug discovery and development appears to be the most important application segment in the benchtop automation market. It is fuelled by the increased requirements in high-throughput screening, accurate liquid handling, and effective sample processing to bring the process of identifying and optimizing potential drug candidates to a faster process.

The automation in this area also ensures fewer manual errors, enhanced reproducibility, and accelerated development processes, which are key factors in the commercialization of new therapies. The fact is that the growing investment in pharmaceutical research also supports the leadership of this segment in benchtop automation.

Which regions are leading the Benchtop Automation market, and why?

The North American benchtop automation market dominates owing to the robust existence of superior research institutes, pharma companies, and biotechnology firms that require superior and accurate laboratory automation systems. There have been huge investments in R&D and innovation in the region, driven by government initiatives that encourage automation in healthcare and life sciences. The established infrastructure and ability to give access to state-of-the-art manufacturers of technology in North America contribute to a higher speed of absorbing benchtop automation systems.

The increasing concern about the minimization of human error, efficiency, and faster drug discovery also contributes to market growth. The presence of qualified talent and a strong funding infrastructure contributes to the demand that justifies the existence of such automated solutions to maintain its position as a leader in the market. More and more, AI and machine learning are being incorporated into benchtop automation, bringing about steadier and more adjustable processes. Due to this ongoing technological advancement, North America is expected to be the place to provide innovative automation tools in laboratories.

The Asia-Pacific benchtop automation market is growing owing to some factors. Highly scaled-up research and development and faster industrialization in emerging economies such as China, Japan, and South Korea have increased the capacity of countries to purchase laboratory automation devices. Due to the high ratio of institutions working in pharmaceutical, biotechnology, and academic research, the use of benchtop automation is focused on efficiency and precision.

The government is putting more funds towards healthcare infrastructure and an appropriate regulatory environment, speeding up the market. The ability to produce within the region cost-effectively and the availability of skilled manpower also make it dominant. Increasing awareness of the benefits of automation in the workflow and minimizing human error in the workplace further supports the growth of the market position of the Asia-Pacific. Overall, the combination of technological progress, economic expansion, and strong development of healthcare preconditions Asia-Pacific to be the leader in the benchtop automation market.

What does the competitive landscape of the Benchtop Automation market look like?

The benchtop automation market is highly competitive due to the growing need for automation in laboratories to enhance efficiency and reproducibility. The important market participants like Tecan Group Ltd., Hamilton Company, Danaher Corporation, Agilent Technologies, and Thermo Fisher Scientific continue to take up the market with pioneering services that match the different research and clinical applications. More recent developments include strategic partnerships and the improvement of products to focus on combining AI and robotics to simplify the workflow.

Hamilton Company has increased its automation line of products in liquid handling, and Tecan has been concerned with improved connectivity and software interface compatibility. Meanwhile, the form of emerging firms, such as Formulatrix and Apricot Designs, is making headway as suppliers of specialized compact automation platforms. The combination of such advancements and increasing implementation in the pharmaceutical and biotech industries is empowering the competitive environment and leading to an overarching growth in the market.

Benchtop Automation Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Benchtop Automation industry?

• In January 2025, Opentrons launched the Flex High-Throughput NGS Workstation. The company made cost-effective, hands-free genomics workflows a reality. The workstation enabled automation for high-throughput next-generation sequencing. It offered labs an affordable solution to streamline their genomic processes.

Report Coverage:

By Product Type

• Automated Pipetting Systems
• Automated Liquid Handling Workstations
• Automated Plate Handling Systems
• Automated Nucleic Acid Purification Systems
• Automated Colony Counters
• Automated Microplate Readers
• Others

By Application

• Genomics
• Proteomics
• Drug Discovery & Development
• Clinical Diagnostics
• Cell Biology
• Others

By Technology

• Robotic Arm Integration
• Optical Imaging Systems
• Microfluidics-based Automation
• Magnetic Bead-based Processing
• Others

By Automation Level

• Semi-automated Systems
• Fully Automated Systems

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Clinical Laboratories
• Contract Research Organizations (CROs)
• Food & Beverage Testing Laboratories
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Tecan Group Ltd.
• Hamilton Company
• Danaher Corporation
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific Inc.
• Eppendorf AG
• Gilson, Inc.
• Sartorius AG
• Hudson Robotics, Inc.
• Analytik Jena AG
• INTEGRA Biosciences AG
• BioTek Instruments
• Formulatrix, Inc.
• Apricot Designs, Inc.

Frequently Asked Questions (FAQs)